Although this cohort included only patients with stage A of the Binet classification (i.e. limited-stage disease), USP7 overexpression in CLL is highly significant and therefore these data suggest that its overexpression may represent a common feature even at the early stages of the disease. The gene discussed is USP7; the disease is B-cell chronic lymphocytic leukemia.